[144] C.H. Robinson Worldwide, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for C.H. Robinson Worldwide, Inc. (CHRW) reports a proposed open‑market sale of 266,732 common shares on 08/27/2025 through Charles Schwab. The filing shows an aggregate market value of $34,080,348 and 118,091,162 shares outstanding, indicating the sale is a small fraction of total shares. The shares being offered were acquired in two open‑market purchases on 02/23/2022 (116,100 shares) and 02/24/2022 (150,632 shares), with broker checks used for payment. The filer states there were no securities sold in the past three months for the account and attests not to possessing undisclosed material adverse information.

Positive

• Timely, detailed disclosure of sale quantity, broker, acquisition dates, payment method, and proposed sale date
• No reported sales in the prior three months for the account, reducing concerns about accelerated disposals

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Form 144 filing; size is immaterial relative to outstanding shares and appears compliant.

The notice documents a proposed brokered sale of 266,732 CHRW common shares with an aggregate market value of $34.08M scheduled for 08/27/2025. Given 118.09M shares outstanding, the proposed sale equals roughly 0.23% of the float, which is unlikely to be market moving. Acquisition dates in February 2022 and use of broker checks are disclosed. Absence of sales in the prior three months reduces near‑term dilution concerns. This is a compliance disclosure rather than a material corporate event.

Corporate Governance Specialist

TL;DR: Disclosure aligns with Rule 144 requirements; no governance red flags in the notice itself.

The filer affirms no undisclosed material adverse information and provides standard acquisition and payment details. The sale will be executed through a named broker on Nasdaq. The filing contains the required representations and shows no clustered or prior three‑month sales for the account, suggesting orderly disposal under Rule 144 rather than unusual insider activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	266732	34080348.00	118091162	08/27/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2022	Open Market Purchase	Market			116100	02/24/2022	Broker Check
Common	02/24/2022	Open Market Purchase	Market			150632	02/25/2022	Broker Check

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CHRW Form 144 report say about the number of shares to be sold?

The notice reports a proposed sale of 266,732 common shares of CHRW.

When is the approximate date of sale listed on the CHRW Form 144?

The filing lists an approximate sale date of 08/27/2025.

What is the aggregate market value of the CHRW shares to be sold?

The aggregate market value is reported as $34,080,348.00.

How and when were the shares being sold originally acquired?

They were acquired via open‑market purchases on 02/23/2022 (116,100 shares) and 02/24/2022 (150,632 shares) with payment by broker check.

Through which broker will the CHRW shares be sold?

The filing names Charles Schwab Corp. as the broker for the proposed sale.